Healthcare provider profile · identity verified

Nauras Hwig, MD

Family Practice · WALDORF, MD · NPI 1396237582

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	506	50
Levothyroxine Sodium	Levothyroxine Sodium	444	33
Eliquis	Apixaban	417	36
Omeprazole	Omeprazole	417	46
Furosemide	Furosemide	371	48
Lisinopril	Lisinopril	340	25
Sertraline Hcl	Sertraline Hcl	322	24
Amlodipine Besylate	Amlodipine Besylate	290	30
Mirtazapine	Mirtazapine	265	20
Losartan Potassium	Losartan Potassium	263	25
Escitalopram Oxalate	Escitalopram Oxalate	244	21
Famotidine	Famotidine	239	20
Buspirone Hcl	Buspirone Hcl	219	24
Duloxetine Hcl	Duloxetine Hcl	203	14
Metoprolol Tartrate	Metoprolol Tartrate	198	25
Potassium Chloride	Potassium Chloride	183	25
Clopidogrel	Clopidogrel Bisulfate	176	18
Donepezil Hcl	Donepezil Hcl	168	15
Trazodone Hcl	Trazodone Hcl	165	26
Tamsulosin Hcl	Tamsulosin Hcl	163	18
Gabapentin	Gabapentin	159	29
Memantine Hcl	Memantine Hcl	154	11
Baclofen	Baclofen	152	14
Pantoprazole Sodium	Pantoprazole Sodium	152	20
Metformin Hcl	Metformin Hcl	150	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	148	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	146	suppressed
Carvedilol	Carvedilol	143	12
Hydrochlorothiazide	Hydrochlorothiazide	143	suppressed
Prednisone	Prednisone	141	24
Risperidone	Risperidone	137	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	33
Levetiracetam	Levetiracetam	118	suppressed
Ropinirole Hcl	Ropinirole Hcl	99	14
Citalopram Hbr	Citalopram Hydrobromide	96	12
Oxybutynin Chloride Er	Oxybutynin Chloride	95	suppressed
Pravastatin Sodium	Pravastatin Sodium	85	suppressed
Divalproex Sodium	Divalproex Sodium	83	suppressed
Metoprolol Succinate	Metoprolol Succinate	81	13
Primidone	Primidone	81	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	79	suppressed
Simvastatin	Simvastatin	79	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	77	suppressed
Montelukast Sodium	Montelukast Sodium	77	11
Carbidopa-Levodopa	Carbidopa/Levodopa	76	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	73	17
Oxybutynin Chloride	Oxybutynin Chloride	68	suppressed
Albuterol Sulfate	Albuterol Sulfate	64	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	62	11
Xarelto	Rivaroxaban	60	suppressed
Oxycodone Hcl	Oxycodone Hcl	59	suppressed
Bupropion Hcl	Bupropion Hcl	53	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	50	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	suppressed
Glipizide	Glipizide	49	suppressed
Novolog Flexpen	Insulin Aspart	48	suppressed
Admelog Solostar	Insulin Lispro	47	suppressed
Glipizide Er	Glipizide	46	suppressed
Amiodarone Hcl	Amiodarone Hcl	45	suppressed
Lactulose	Lactulose	45	suppressed
Calcium Acetate	Calcium Acetate	43	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	43	suppressed
Atenolol	Atenolol	39	suppressed
Insulin Aspart Flexpen	Insulin Aspart	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	38	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Olanzapine	Olanzapine	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	34	suppressed
Lidocaine Hcl	Lidocaine Hcl	33	19
Lorazepam	Lorazepam	33	16
Sucralfate	Sucralfate	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	20
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Valsartan	Valsartan	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Latanoprost	Latanoprost	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	11
Doxycycline Monohydrate	Doxycycline Monohydrate	28	15
Fluticasone Propionate	Fluticasone Propionate	28	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	suppressed
Cephalexin	Cephalexin	27	18
Clonazepam	Clonazepam	27	suppressed
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Enulose	Lactulose	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Azithromycin	Azithromycin	23	16
Digoxin	Digoxin	23	suppressed
Calcitriol	Calcitriol	22	suppressed
Fluconazole	Fluconazole	22	13
Klor-Con 10	Potassium Chloride	22	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	22	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	21	13
Topiramate	Topiramate	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	13
Brilinta	Ticagrelor	19	suppressed
Haloperidol	Haloperidol	19	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	11
Ertapenem	Ertapenem Sodium	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Lubiprostone	Lubiprostone	18	suppressed
Trimethoprim	Trimethoprim	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	11
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Dantrolene Sodium	Dantrolene Sodium	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	11
Entresto	Sacubitril/Valsartan	16	suppressed
Methimazole	Methimazole	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Renvela	Sevelamer Carbonate	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Cefdinir	Cefdinir	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Finasteride	Finasteride	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nystatin	Nystatin	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Linzess	Linaclotide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error